shot-button
Maharashtra Elections 2024 Maharashtra Elections 2024
Home > News > India News > Article > Centre to import 45 lakh vials of Remdesivir

Centre to import 4.5 lakh vials of Remdesivir

Updated on: 30 April,2021 12:00 AM IST  |  New Delhi
PTI |

The first consignment of 75,000 vials will reach India on Friday.

Centre to import 4.5 lakh vials of Remdesivir

Photo for representational purpose

The government has placed orders for import of 4.5 lakh vials of antiviral drug Remdesivir with the first consignment of 75,000 vials expected to reach Indian shores on Friday, Chemicals and Fertilisers Ministry said in a statement.


The government has started importing the vital drug Remdesivir from other countries to ease its shortage in the country, the ministry said.


The first consignment of 75,000 vials will reach India on Friday, it added.


Demand for Remdesivir has gone up manifold in the country with a surge in COVID-19 cases. The antiviral drug is used in the treatment of the infectious disease.

HLL Lifecare Ltd, a Government of India owned company, has ordered 4,50,000 vials of Remdesivir from M/s Gilead Sciences Inc USA and Egyptian Pharma Company, M/s Eva Pharma, the release said.

It is expected that Gilead Sciences will dispatch 75,000 to 1,00,000 vials in the next one or two days, it noted.

Further, one lakh vials will also be supplied before or by May 15, the release said.

EVA Pharma will supply around 10,000 vials initially followed by 50,000 vials every 15 days or till July, it added.

This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever.

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!


Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK